Oncoplastic Breast Surgery: Optimizing Resection Margins in Addition to Aesthetic Outcomes.
Abstract
[OBJECTIVE] This study aims to determine whether oncoplastic surgery improves resection margins compared to lumpectomy alone in patients undergoing breast conserving therapy, as determined by re-excision rates.
[BACKGROUND] Prior studies have demonstrated that oncoplastic breast surgery results in better aesthetic outcomes than lumpectomy alone in select patient cohorts. However, there is a dearth of literature on whether oncoplastic breast surgery also provides oncologic benefit.
[METHODS] This is a retrospective cohort investigation of women who underwent breast conserving therapy at our institution between 2010 and 2023. Breast cancer patients who received either lumpectomy alone or oncoplastic breast surgery during this period were included. The rate of re-excision of margins within the 6-month period following the index procedure was compared between patients who underwent lumpectomy along and those who underwent oncoplastic breast surgery.
[RESULTS] Of 4,673 study patients, 4,164 (89.6%) underwent lumpectomy alone and 488 (10.4%) underwent oncoplastic breast surgery. Oncoplastic surgery became significantly more prevalent over the course of the study period (p = 0.04). The re-excision rate was higher in the lumpectomy cohort that in the oncoplastic surgery cohort (17% vs. 13%). After adjusting for potential confounders using propensity score matching, oncoplastic surgery was associated with significantly lower odds of re-excision (OR 0.7, 95% confidence interval 0.4-1.0, p = 0.05).
[CONCLUSIONS] Oncoplastic surgery may help to better achieve clear surgical margins compared to lumpectomy alone, and an increasing number of patients are receiving oncoplastic breast surgery. This suggests that, whenever possible, efforts should be made to offer oncoplastic surgery to appropriately selected patients.
[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
[BACKGROUND] Prior studies have demonstrated that oncoplastic breast surgery results in better aesthetic outcomes than lumpectomy alone in select patient cohorts. However, there is a dearth of literature on whether oncoplastic breast surgery also provides oncologic benefit.
[METHODS] This is a retrospective cohort investigation of women who underwent breast conserving therapy at our institution between 2010 and 2023. Breast cancer patients who received either lumpectomy alone or oncoplastic breast surgery during this period were included. The rate of re-excision of margins within the 6-month period following the index procedure was compared between patients who underwent lumpectomy along and those who underwent oncoplastic breast surgery.
[RESULTS] Of 4,673 study patients, 4,164 (89.6%) underwent lumpectomy alone and 488 (10.4%) underwent oncoplastic breast surgery. Oncoplastic surgery became significantly more prevalent over the course of the study period (p = 0.04). The re-excision rate was higher in the lumpectomy cohort that in the oncoplastic surgery cohort (17% vs. 13%). After adjusting for potential confounders using propensity score matching, oncoplastic surgery was associated with significantly lower odds of re-excision (OR 0.7, 95% confidence interval 0.4-1.0, p = 0.05).
[CONCLUSIONS] Oncoplastic surgery may help to better achieve clear surgical margins compared to lumpectomy alone, and an increasing number of patients are receiving oncoplastic breast surgery. This suggests that, whenever possible, efforts should be made to offer oncoplastic surgery to appropriately selected patients.
[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 10 | |
| 해부 | lumpectomy
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | Breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | Breast cancer patients
|
scispacy | 1 | ||
| 질환 | lumpectomy
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 |
MeSH Terms
Humans; Female; Margins of Excision; Retrospective Studies; Breast Neoplasms; Mastectomy, Segmental; Middle Aged; Esthetics; Treatment Outcome; Reoperation; Adult; Mammaplasty; Cohort Studies; Aged; Risk Assessment
📑 인용 관계
이 논문이 참조한 문헌 24
- Outcomes of Margin Reexcision after Oncoplastic Breast Reduction.
- Results from the American Society of Breast Surgeons Oncoplastic Surgery Committee 2017 Survey: Curr…
- Oncoplastic breast surgery: comprehensive review.
- Positive Margins After Oncoplastic Surgery for Breast Cancer.
외부 PMID 20건 (DB 미수집)
- PMID 10667193 ↗
- PMID 12433599 ↗
- PMID 20124831 ↗
- PMID 20195109 ↗
- PMID 23849158 ↗
- PMID 28414115 ↗
- PMID 28586788 ↗
- PMID 29396125 ↗
- PMID 30855383 ↗
- PMID 31440079 ↗
- PMID 31508489 ↗
- PMID 32761931 ↗
- PMID 33225394 ↗
- PMID 33711697 ↗
- PMID 34422626 ↗
- PMID 34713449 ↗
- PMID 35398000 ↗
- PMID 36016619 ↗
- PMID 36507913 ↗
- PMID 37306849 ↗
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- The Plastic Surgery In-Service Examination: A Scoping Review.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.